EHMTI-0105. CGRP and VIP levels as predictors of efficacy of onabotulinumtoxin type A in chronic migraine

The Journal of Headache and Pain

Meeting Abstract

关键词: Public Health;    Internal Medicine;    Migraine;    Migraine Attack;    Chronic Migraine;   

DOI  :  10.1186/1129-2377-15-S1-E24

来源: Springer

【 授权许可】

CC BY   
© Cernuda-Morollón et al; licensee Springer. 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.